Morgan Stanley’s Fractyl Health GUTS Stock Holding History

Morgan Stanley’s Portfolio GUTS Stock Details GUTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$227K	Sell	495,901 -160,581	-24%	-$148K	﹤0.01%	5820
2025 Q4	$1.44M	Buy	656,482 +226,251	+53%	+$364K	﹤0.01%	4998
2025 Q3	$684K	Buy	430,231 +273,341	+174%	+$355K	﹤0.01%	5354
2025 Q2	$254K	Sell	156,890 -3,149	-2%	-$5.09K	﹤0.01%	5757
2025 Q1	$190K	Sell	160,039 -110,786	-41%	-$177K	﹤0.01%	5748
2024 Q4	$558K	Buy	270,825 +103,549	+62%	+$241K	﹤0.01%	5375
2024 Q3	$423K	Buy	167,276 +94,312	+129%	+$308K	﹤0.01%	5478
2024 Q2	$312K	Sell	72,964 -205,576	-74%	-$1.32M	﹤0.01%	5492
2024 Q1	$2.06M	Buy	+278,540	New	+$2.35M	﹤0.01%	4551

Other funds holding GUTS

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

PFCS

Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Catalio Capital Management New York $479M AUM 140.7% 1-Year Est. Return

GCGM

General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return

DMC

Deer Management Company Larchmont, New York $622M AUM 24.27% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley's GUTS Position: Q1 2026 in Review

Morgan Stanley reduced its Fractyl Health (GUTS) stake by 24% in Q1 2026, selling an estimated $148K and leaving 495,901 shares worth $227K. The position accounts for ﹤0.01% of the portfolio, ranked #5820.

Morgan Stanley first reported a position in GUTS in Q1 2024 and has held it in 9 quarters since. The position peaked at $2.06M in Q1 2024. 83 funds tracked by Wall St. Rank hold GUTS as of Q1 2026.

Morgan Stanley held 495,901 shares of Fractyl Health worth $227K as of Q1 2026.
Morgan Stanley sold 160,581 Fractyl Health shares in Q1 2026, an estimated $148K.
Fractyl Health made up ﹤0.01% of Morgan Stanley's portfolio in Q1 2026, its #5820 holding.
Morgan Stanley first reported a position in Fractyl Health in Q1 2024 and has held it in 9 quarters since.
Morgan Stanley's Fractyl Health position peaked at $2.06M in Q1 2024.
83 funds tracked by Wall St. Rank held Fractyl Health as of Q1 2026.

Based on Morgan Stanley's 13F filing for Q1 2026, filed 15 May 2026.